Latest International Expansion News

Microba Life Sciences is targeting a $6 million capital raise through a $1 million Securities Purchase Plan and a $5 million Placement, both subject to shareholder approval. The funds aim to accelerate diagnostics growth and develop a new testing product.

Norwood Systems has landed a paid pilot trial with a major UK telecom to showcase its OpenSpan AI orchestration and CogVoice applications, marking a key step in its international expansion.

Harvest Technology Group has transitioned from assessing to actively executing its international defence market strategy by engaging a US national security advisory firm and appointing Dr Oleksandra Molloy as Defence Strategic Advisor for Europe.

Memphasys has locked in a 12-month exclusive supply agreement with Monash IVF for its Felix™ sperm selection system, marking its biggest commercial contract to date and setting a foundation for recurring revenue.

Beamtree Holdings has appointed Gareth Pye as its new CEO, aiming to pivot towards stronger operational execution and commercial focus amid ongoing international expansion.

Vinyl Group has acquired Time Out Australia from Time Out England for nominal consideration, boosting its digital audience reach to 55% of Australians and completing a $2.4 million placement to fund integration. The acquisition is expected to be earnings accretive in FY27, reinforcing Vinyl's position as a leading cultural media platform.

SPC Global has finalised its $100 million entitlement offer, allocating most shortfall shares to sub-underwriters and positioning the company to reduce debt and support growth.

GCM Corporation is seeking shareholder approval for a 15-to-1 share consolidation as a strategic step towards a potential listing on a US national stock exchange, aiming to boost international capital access and market visibility.

OMG Group's net sales hit approximately $6.2 million on a moving annual total basis, marking a 57% increase year-on-year, driven by ecommerce growth and key international distribution deals.

Little Green Pharma (ASX:LGP) has completed its merger with Cannatrek, creating a dominant player in Australia and Europe’s medicinal cannabis market with a majority stake held by former Cannatrek shareholders.

4DMedical has leapfrogged into the European lung health market by acquiring Austrian AI imaging firm contextflow, gaining immediate commercial presence and a CE-marked lung cancer screening solution.

Memphasys has inked its first exclusive commercialization agreement in South-East Asia with TMSC Vietnam, targeting the fast-growing Vietnamese IVF sector with its Felix™ sperm separation system. The two-year contract, valued at A$530,000, hinges on regulatory approval expected by August 2026.